Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.
2011 update of the drug resistance mutations in HIV-1.
Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study.
Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors.
Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure.
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.
Clinical management of HIV-1 resistance.
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.
Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time.
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.